Atlas Trials

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT01414257 · COMPLETED

Trial details

NCT number
NCT01414257
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
ArthritisRheumatoidHigh Dose
Start date
2011-05-01
Primary completion
2014-03-01
Enrollment
2860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.